(Press-News.org) A new study led by researchers at the American Cancer Society (ACS) highlights the lasting financial impact of a cancer diagnosis for many working-age adults and their families in the United States. It shows a cancer diagnosis and the time required for its treatment can result in employment disruptions, loss of household income and loss of employment-based health insurance coverage, leading to financial hardship. When combined with high out-of-pocket costs for cancer care, nearly 60% of working-age cancer survivors report at least one type of financial hardship, such as being unable to afford medical bills, distress and worry, or delaying or forgoing needed care because of cost. The findings are published today in CA: A Cancer Journal for Clinicians.
“While the rising costs of cancer care and subsequent medical financial hardship for cancer survivors and families are well-documented in the United States, little attention has been paid to how employment and household income can be affected by a cancer diagnosis and treatment,” said lead study author Dr. Robin Yabroff, scientific vice president, health services research at the American Cancer Society. “With nearly half of cancer survivors of working age and not yet age-eligible for Medicare coverage, understanding the potential effects of cancer diagnosis and treatment on employment, income, and access to employer-based health insurance coverage is essential.”
Study researchers used a composite patient case to illustrate the potential adverse consequences of cancer diagnosis and treatment, including employment disruptions while receiving cancer care, loss of income for unpaid time away from work, and loss of access to employment-based health insurance coverage, if unable to maintain employment. The authors also summarize existing research and provide nationally representative estimates of multiple aspects of financial hardship from 2019-2021, the most recently available years of the National Health Interview Survey (NHIS). The NHIS collects information about health conditions, including but not limited to cancer diagnoses, health status, employment, health insurance, socioeconomic status and experience with health care from nearly 90,000 individuals in 35,000 households each year.
“There are opportunities for a variety of stakeholders to mitigate financial hardship and assist patients with cancer and their families,” added Dr. Yabroff. “Federal, state and local policies can increase availability of comprehensive and affordable health insurance coverage and ensure job protections for working adults.”
“Today’s findings reiterate the critical role access to affordable, quality care and paid family medical leave plays in reducing the financial toll of cancer on those diagnosed – particularly while they are of working age,” said Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN). “A majority of cancer patients and survivors (74%) report being forced to miss work due to their illness, most of whom report missing more than four weeks of work, according to an ACS CAN study. No one should be forced to choose between their treatment and their employment. To truly protect patients from the high costs of cancer, Congress must enact paid family and medical leave as well as provide tangible options for affordable health coverage outside of employer-sponsored plans by making permanent the enhanced Marketplace subsidies that allow millions who otherwise have no affordable coverage option to enroll in Marketplace plans.”
Study authors emphasize that employers, cancer care delivery organizations and non-profit organizations can also guide efforts to help patients with cancer avoid financial hardship. Employers can offer robust coverage and benefits options, paid and unpaid leave and other workplace accommodations to help reduce employment disruptions and loss of income during cancer treatment. Within cancer care delivery, providers can screen patients for financial hardship, connect patients with relevant services, and make referrals for occupational medicine, rehabilitation care and physical therapy to facilitate return to work and usual activities during and after cancer treatment.
Other ACS authors involved in this study include: Jingxuan Zhao, Dr. Xuesong Han and Dr. Zhiyuan Zheng.
# # #
About the American Cancer Society
The American Cancer Society is a leading cancer-fighting organization with a vision to end cancer as we know it, for everyone. For more than 100 years, we have been improving the lives of people with cancer and their families as the only organization combating cancer through advocacy, research, and patient support. We are committed to ensuring everyone has an opportunity to prevent, detect, treat, and survive cancer. To learn more, visit cancer.org or call our 24/7 helpline at 1-800-227-2345. Connect with us on Facebook, Twitter, and Instagram.
END
“The ultimate goal of exploiting model organisms to screen for anti-aging interventions is to identify treatments that might translate to healthy lifespan extension in humans.”
BUFFALO, NY- April 23, 2024 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 7, entitled, “The coupling between healthspan and lifespan in Caenorhabditis depends on complex interactions between compound intervention and genetic background.”
Aging is characterized by declining health that results ...
USC faculty members Paul K. Newton and Nicolás Lell Benavides have been awarded prestigious Guggenheim Fellowships for 2024.
Newton, professor of aerospace and mechanical engineering and mathematics at the USC Viterbi School of Engineering, and Benavides, a lecturer at the USC Thornton School of Music, were chosen by the John Simon Guggenheim Memorial Foundation from nearly 3,000 applicants. They are among 188 inductees chosen this year for their excellence in scholarship and the arts.
“Humanity faces some profound existential challenges,” said Edward Hirsch, ...
The council of the American Association for the Advancement of Science has elected USC faculty members Pinchas Cohen, Andrea Hodge, Jay Lieberman and Gaurav Sukhatme to the ranks of AAAS fellows.
The honor, which recognizes researchers whose “efforts on behalf of the advancement of science or its applications are scientifically or socially distinguished,” is among the most prized in academia.
The recognition honors excellence in research, technology, industry and government, teaching, and communicating and interpreting science to the public. The new cohort joins more than 40 of their USC peers already inducted into AAAS.
The newly elected AAAS ...
Alzheimer’s disease causes significant problems with memory, thinking and behavior and is the most common form of dementia, affecting more than 50 million people around the world each year. This number is expected to triple by the year 2050.
Using their own state-of-the art imaging technologies, scientists at the University of California San Diego have now revealed how the metabolism of lipids, a class of molecule that includes fats, oils and many hormones, is changed in Alzheimer’s disease. They also revealed a new strategy to target this metabolic system with new and existing drugs. The findings are published in Cell Metabolism.
“Lipids ...
Turbulence is ubiquitous in nature. It exists everywhere, from our daily lives to the distant universe, while being labelled as “the last great unsolved problem of classical physics” by Richard Feynman. Prof. Dr. Huirong Yan and her group from the Institute of Physics and Astronomy at the University of Potsdam and DESY have now discovered a long-predicted phenomenon: the weak-to-strong transition in small amplitude space plasma turbulence. The discovery was made by analyzing data from ESA’s Cluster mission – a constellation of four spacecraft flying in formation around Earth and investigating how the Sun and the Earth interact.
The ...
Researchers from the University of Missouri-Kansas City, School of Computing and Engineering, and independent researchers have developed a groundbreaking model, dubbed GREENSKY, that significantly enhances the energy efficiency and operational time of Unmanned Aerial Vehicles (UAVs) in cellular networks.
In the ever-evolving landscape of wireless communication, UAVs play a pivotal role, especially in rural, remote, and disaster-struck areas where traditional network infrastructure is absent. ...
A study analyzing a large sample of Medicare admissions at nearly 2,000 acute care hospitals nationwide during 2019 found that most hospitals—nearly four out of five—admitted a significantly different proportion of Black fee-for-service Medicare patients age 65 and older compared to the proportion of the same group of patients admitted to any hospital in that hospital’s market area.
The researchers say that understanding hospital choices within neighborhoods and markets could ...
In a study of patients who smoked when they were diagnosed with laryngeal cancer, those who quit smoking before starting chemotherapy or radiation responded better to treatment, were less likely to need their voice boxes surgically removed, and lived significantly longer than those who continued to smoke. The research, from the University of Oklahoma, is published in the journal Otolaryngology-Head and Neck Surgery.
The study’s lead author, Lurdes Queimado, M.D., Ph.D., said the findings underscore the importance of integrating tobacco cessation programs into treatment plans for cancer of the larynx, an area of the throat involved in breathing, swallowing ...
ALBUQUERQUE, N.M. — Sandia National Laboratories and the Kansas City National Security Campus completed a crucial weapons component development milestone, prior to full rate production.
The Mark 21 Replacement Fuze interfaces with the W87-0 warhead for deployment onto the Minuteman III and, eventually, the Sentinel Intercontinental Ballistic Missile.
The first production unit of the replacement fuze was approved through the National Nuclear Security Administration’s rigorous Quality Assurance Inspection Procedure ...
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced the approval of funding awards totaling more than $150 million to support new patient-centered comparative clinical effectiveness research (CER) studies, research to strengthen the rigor and quality of patient-centered CER and a project to implement the findings of PCORI-funded research into practice.
Among the nine awards for patient-centered CER, two include support for large, two-phased trials comparing approaches to treatments for heart failure and asthma. Two other large studies will compare health system strategies to improve hypertension control, and another will evaluate ...